You have 8 free searches left this month | for more free features.

ABBV-647

Showing 76 - 100 of 109

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-3373, Placebo for ABBV-3373, Adalimumab)

Completed
  • Rheumatoid Arthritis (RA)
  • Huntsville, Alabama
  • +29 more
Jun 29, 2021

Psoriasis Trial (risankizumab, adalimumab, for risankizumab)

Completed
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Progressive Supranuclear Palsy Trial in Worldwide (Placebo, ABBV-8E12)

Terminated
  • Progressive Supranuclear Palsy
  • Birmingham, Alabama
  • +65 more
Feb 1, 2021

Progressive Supranuclear Palsy (PSP) Trial in Worldwide (ABBV-8E12, Placebo solution for IV infusion on Day 15)

Terminated
  • Progressive Supranuclear Palsy (PSP)
  • ABBV-8E12
  • Placebo solution for IV infusion on Day 15
  • Birmingham, Alabama
  • +41 more
Feb 1, 2021

Advanced Solid Tumors Cancer Trial in Australia, Israel, United States (ABBV-321)

Completed
  • Advanced Solid Tumors Cancer
  • Springdale, Arkansas
  • +17 more
May 5, 2021

Acute Myeloid Leukemia (AML) Trial in United States (ABBV-744)

Terminated
  • Acute Myeloid Leukemia (AML)
  • Orange, California
  • +6 more
Mar 22, 2021

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Completed
  • Rheumatoid Arthritis (RA)
  • Huntsville, Alabama
  • +114 more
Apr 6, 2021

Multiple Myeloma Trial in Worldwide (Eftozanermin alfa, Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Eftozanermin alfa
  • +2 more
  • Atlanta, Georgia
  • +18 more
Oct 12, 2022

Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-428, Nivolumab)

Completed
  • Advanced Solid Tumors Cancer
  • Scottsdale, Arizona
  • +14 more
Jul 17, 2020

Colorectal Cancer Trial in United States (SC-006, ABBV-181)

Terminated
  • Colorectal Cancer
  • Fayetteville, Arkansas
  • +8 more
Feb 18, 2020

Cancer, Breast Cancer, NSCLC Trial in United States (ABBV-075, Venetoclax)

Completed
  • Cancer
  • +7 more
  • Scottsdale, Arizona
  • +9 more
Nov 27, 2019

Crohn Disease Trial in Worldwide (Risankizumab 600 mg IV, Risankizumab 180 mg SC)

Completed
  • Crohn Disease
  • Risankizumab 600 mg IV
  • Risankizumab 180 mg SC
  • Chevy Chase, Maryland
  • +27 more
Apr 9, 2020

Progressive Supranuclear Palsy (PSP) Trial in La Jolla, Dallas (ABBV-8E12)

Completed
  • Progressive Supranuclear Palsy (PSP)
  • La Jolla, California
  • +1 more
Dec 2, 2019

Parkinson's Disease (PD) Trial in United States (ABBV-951)

Completed
  • Parkinson's Disease (PD)
  • Glendale, California
  • +6 more
Nov 13, 2019

Primary Tauopathy Corticobasal Degeneration Syndrome (CBD) Trial (ABBV-8E12)

No longer available
  • Primary Tauopathy Corticobasal Degeneration Syndrome (CBD)
  • (no location specified)
Aug 16, 2019

Arthritis, Psoriatic Trial (risankizumab, for risankizumab)

Completed
  • Arthritis, Psoriatic
  • (no location specified)
May 28, 2019

Asthma Trial in Worldwide (, risankizumab)

Completed
  • Asthma
  • Costa Mesa, California
  • +64 more
Mar 18, 2019

Advanced Solid Tumors Cancer Trial in Sunto-gun, Chuo-ku (ABBV-399)

Completed
  • Advanced Solid Tumors Cancer
  • Sunto-gun, Shizuoka, Japan
  • +1 more
Mar 12, 2019

Psoriasis Trial (Risankizumab, Placebo)

Completed
  • Psoriasis
  • (no location specified)
Sep 25, 2019

Parkinson's Disease (PD) Trial in United States (ABBV-951)

Completed
  • Parkinson's Disease (PD)
  • Sun City, Arizona
  • +11 more
Mar 12, 2019

Psoriasis Trial (Risankizumab)

Completed
  • Psoriasis
  • (no location specified)
Oct 21, 2019

Cancer Trial in United States (SC-004, ABBV-181)

Terminated
  • Cancer
  • Birmingham, Alabama
  • +11 more
May 10, 2019

Ovarian Cancer Trial in United States (SC-003, SC-003 in combination with ABBV-181)

Terminated
  • Ovarian Cancer
  • SC-003
  • SC-003 in combination with ABBV-181
  • Fayetteville, Arkansas
  • +15 more
Jan 2, 2019

Crohn Disease Trial (risankizumab IV, risankizumab SC, Placebo)

Completed
  • Crohn Disease
  • risankizumab IV
  • +2 more
  • (no location specified)
Oct 25, 2018